Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of rupatifen fumarate capsules in seasonal allergic rhinitis
CTR20234040Phase 2Completed
- Sponsor
- Lijiexun Pharmaceutical
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rupatadine in seasonal allergic rhinitis (SAR), sponsored by Lijiexun Pharmaceutical. Started Dec 2023; status: completed.
02
Drugs
rupatadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20234040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234040.